Bruce D. Weintraub
Algemeen Directeur bij Trophogen, Inc.
Actieve functies van Bruce D. Weintraub
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Trophogen, Inc.
Trophogen, Inc. BiotechnologyHealth Technology Trophogen, Inc. develops glycoprotein hormones and therapeutic applications. The firm's research is focused on developing super-agonists and antagonists of cystine knot growth factors and therapy and imaging of thyroid, ovarian, breast, prostate and testicular cancers. The company was founded by Bruce D. Weintraub and Mariusz W. Szkudlinski in July 2001 and is headquartered in Rockville, MD. | Algemeen Directeur | 01-07-2001 | - |
Oprichter | 25-02-2010 | - | |
President | 01-07-2001 | - | |
Operationeel Directeur | 01-07-2001 | 21-01-2013 | |
Hoofd Techniek/Wetenschap/O&O | 01-07-2001 | 21-01-2013 |
Loopbaan van Bruce D. Weintraub
Eerdere bekende functies van Bruce D. Weintraub
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
University of Maryland | Corporate Officer/Principal | 01-01-1996 | 01-01-2001 |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
The Endocrine Society | Corporate Officer/Principal | - | - |
Opleiding van Bruce D. Weintraub
Princeton University | Undergraduate Degree |
Harvard University | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 6 |
Operationeel
Corporate Officer/Principal | 3 |
Chief Executive Officer | 1 |
Chief Operating Officer | 1 |
Sectoraal
Consumer Services | 4 |
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Trophogen, Inc.
Trophogen, Inc. BiotechnologyHealth Technology Trophogen, Inc. develops glycoprotein hormones and therapeutic applications. The firm's research is focused on developing super-agonists and antagonists of cystine knot growth factors and therapy and imaging of thyroid, ovarian, breast, prostate and testicular cancers. The company was founded by Bruce D. Weintraub and Mariusz W. Szkudlinski in July 2001 and is headquartered in Rockville, MD. | Health Technology |
The Endocrine Society |
- Beurs
- Insiders
- Bruce D. Weintraub
- Ervaring